C.Q. Pharmaceutical Holding Co., Ltd. (SHE:000950)
China · Delayed Price · Currency is CNY 5.47
+0.03 (0.55%)
Jul 31, 2026, 3:04 PM CST
SHE:000950 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 4,892 | 6,684 | 9,392 | 9,149 | 7,422 | 5,665 |
Trading Asset Securities | - | - | - | - | 6.9 | 12.4 |
Cash & Short-Term Investments | 4,892 | 6,684 | 9,392 | 9,149 | 7,429 | 5,677 |
Cash Growth | -29.85% | -28.83% | 2.65% | 23.15% | 30.86% | 20.98% |
Accounts Receivable | 40,081 | 37,111 | 34,423 | 33,719 | 29,620 | 26,988 |
Other Receivables | 2,351 | 1,651 | 1,893 | 1,443 | 1,389 | 1,243 |
Receivables | 42,432 | 38,762 | 36,316 | 35,162 | 31,009 | 28,231 |
Inventory | 9,908 | 10,041 | 9,977 | 8,603 | 7,863 | 6,051 |
Prepaid Expenses | - | - | - | - | 19.44 | - |
Other Current Assets | 2,084 | 1,465 | 1,735 | 1,621 | 2,388 | 1,379 |
Total Current Assets | 59,317 | 56,952 | 57,420 | 54,534 | 48,708 | 41,338 |
Property, Plant & Equipment | 2,664 | 2,629 | 2,624 | 2,626 | 2,650 | 2,557 |
Long-Term Investments | 3,447 | 3,338 | 3,268 | 3,091 | 3,032 | 2,958 |
Goodwill | 1,431 | 1,431 | 1,461 | 1,501 | 1,509 | 1,461 |
Other Intangible Assets | 310.62 | 317.63 | 311.73 | 320.01 | 263.57 | 262.32 |
Long-Term Accounts Receivable | - | 38.17 | 85.28 | 49.49 | 1.41 | 2.78 |
Long-Term Deferred Tax Assets | 692.96 | 672.82 | 438.89 | 328.69 | 225.67 | 255 |
Long-Term Deferred Charges | 177.32 | 179.62 | 178.7 | 173.63 | 123.41 | 105.23 |
Other Long-Term Assets | 754.52 | 681.11 | 770.04 | 798.8 | 679.13 | 761.64 |
Total Assets | 68,795 | 66,239 | 66,630 | 63,481 | 57,192 | 49,700 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Accounts Payable | 20,121 | 20,222 | 18,165 | 17,437 | 13,761 | 12,126 |
Accrued Expenses | 203.98 | 792.04 | 678.31 | 583.19 | 523.3 | 492 |
Short-Term Debt | 21,053 | 20,266 | 16,243 | 16,763 | 17,079 | 13,806 |
Current Portion of Long-Term Debt | 1,882 | 605.15 | 2,364 | 1,540 | 3,799 | 430.56 |
Current Portion of Leases | - | 110.3 | 166.37 | 170.72 | 154.9 | 156.81 |
Current Income Taxes Payable | 280.79 | 200.93 | 111.48 | 139.08 | 126.97 | 155.39 |
Current Unearned Revenue | 1,153 | 764.67 | 528.08 | 447.73 | 716.16 | 215.53 |
Other Current Liabilities | 4,907 | 3,780 | 5,807 | 5,780 | 4,515 | 4,342 |
Total Current Liabilities | 49,601 | 46,741 | 44,064 | 42,860 | 40,674 | 31,724 |
Long-Term Debt | 1,913 | 2,426 | 5,370 | 4,439 | 3,123 | 5,434 |
Long-Term Leases | 303.63 | 284.56 | 259.06 | 266.34 | 228.74 | 226.31 |
Long-Term Unearned Revenue | 62.95 | 64.49 | 63.62 | 68.02 | 73.08 | 76.25 |
Pension & Post-Retirement Benefits | - | 50.64 | 54.45 | 53.26 | 55.38 | 57.53 |
Long-Term Deferred Tax Liabilities | 24.08 | 20.98 | 68.54 | 54.83 | 47.14 | 57.64 |
Other Long-Term Liabilities | 143.34 | 97.18 | 287.01 | 274.16 | 280.13 | 357.31 |
Total Liabilities | 52,049 | 49,685 | 50,167 | 48,016 | 44,481 | 37,934 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Common Stock | 1,728 | 1,728 | 1,728 | 1,728 | 1,743 | 1,743 |
Additional Paid-In Capital | 2,492 | 2,492 | 2,481 | 2,494 | 2,436 | 2,437 |
Retained Earnings | 7,679 | 7,508 | 7,225 | 7,081 | 6,560 | 5,720 |
Treasury Stock | -81.15 | -81.15 | - | - | -41.9 | -41.9 |
Comprehensive Income & Other | -110.18 | -110.18 | -107.62 | -86.79 | -45.76 | -36.92 |
Total Common Equity | 11,707 | 11,536 | 11,327 | 11,216 | 10,652 | 9,821 |
Minority Interest | 5,040 | 5,018 | 5,136 | 4,250 | 2,059 | 1,946 |
Shareholders' Equity | 16,747 | 16,554 | 16,463 | 15,465 | 12,710 | 11,767 |
Total Liabilities & Equity | 68,795 | 66,239 | 66,630 | 63,481 | 57,192 | 49,700 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Total Debt | 25,152 | 23,693 | 24,403 | 23,179 | 24,384 | 20,054 |
Net Cash (Debt) | -20,259 | -17,009 | -15,012 | -14,030 | -16,955 | -14,377 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -11.66 | -9.68 | -8.49 | -8.09 | -9.79 | -8.29 |
Filing Date Shares Outstanding | 1,728 | 1,713 | 1,728 | 1,728 | 1,743 | 1,692 |
Total Common Shares Outstanding | 1,728 | 1,713 | 1,728 | 1,728 | 1,743 | 1,692 |
Working Capital | 9,716 | 10,211 | 13,356 | 11,674 | 8,034 | 9,613 |
Book Value Per Share | 6.77 | 6.74 | 6.55 | 6.49 | 6.11 | 5.81 |
Tangible Book Value | 9,965 | 9,787 | 9,554 | 9,394 | 8,879 | 8,098 |
Tangible Book Value Per Share | 5.77 | 5.71 | 5.53 | 5.44 | 5.09 | 4.79 |
Buildings | - | 2,210 | 2,201 | 2,212 | 2,106 | 1,773 |
Machinery | - | 1,330 | 1,236 | 1,128 | 956.1 | 736.98 |
Construction In Progress | - | 198.07 | 67.63 | 1.76 | 169.58 | 474.58 |